MEI Return On Tangible Assets from 2010 to 2025
| MEIP Stock | USD 2.32 0.03 1.28% |
Check MEI Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEI Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . MEI financial statements analysis is a perfect complement when working with MEI Pharma Valuation or Volatility modules.
MEI |
About MEI Pharma Financial Statements
MEI Pharma shareholders use historical fundamental indicators, such as Return On Tangible Assets, to determine how well the company is positioned to perform in the future. Although MEI Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in MEI Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on MEI Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California. Mei Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.
Additional Tools for MEI Stock Analysis
When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.